Clinical Trial Update: Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating apatinib plus etoposide capsules for advanced small cell lung cancer (SCLC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• Etoposide capsules (etoposide)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN